Skip to main content

China hits back at South Korea, Japan in first Covid retaliation

China hits back at South Korea, Japan in first Covid retaliation

 China has suspended issuing some visas for South Korea and Japan in Beijing’s first retaliation against Covid-related curbs on Chinese travelers.

Chinese consulates in South Korea will stop issuing short-term visas for visits, business, tourism, medical care, transit, and personal matters from Tuesday, the Chinese Embassy in Seoul said in a statement. The suspension will be adjusted if South Korea removes its “discriminative inbound restrictive measures” targeting China, it added.

China also suspended visa issuance to Japanese travelers, Kyodo reported, citing unidentified people in the travel industry.

The moves e represent China’s first attempt at retaliation after a raft of nations recently implemented testing requirements for travelers from the country. The dismantling of China’s Covid Zero policy after almost three years has sparked a deluge of infections that, combined with a lack of information about how many people are sick or dying, has raised concerns over the possibility that new virus strains will emerge.

Shares of some South Korean stocks linked to travel and tourism slid in afternoon trading, with cosmetics maker Amorepacific Corp. falling as much as 6.2% and Korean Air slipping 1.3%.

China has suspended issuing some visas for South Korea and Japan in Beijing’s first retaliation against Covid-related curbs on Chinese travelers.

Chinese consulates in South Korea will stop issuing short-term visas for visits, business, tourism, medical care, transit, and personal matters from Tuesday, the Chinese Embassy in Seoul said in a statement. The suspension will be adjusted if South Korea removes its “discriminative inbound restrictive measures” targeting China, it added.

China also suspended visa issuance to Japanese travelers, Kyodo reported, citing unidentified people in the travel industry.

The moves represent China’s first attempt at retaliation after a raft of nations recently implemented testing requirements for travelers from the country. The dismantling of China’s Covid Zero policy after almost three years has sparked a deluge of infections that, combined with a lack of information about how many people are sick or dying, has raised concerns over the possibility that new virus strains will emerge.

Shares of some South Korean stocks linked to travel and tourism slid in afternoon trading, with cosmetics maker Amorepacific Corp. falling as much as 6.2% and Korean Air slipping 1.3%.

“The Korean government’s strengthened prevention measures for entrants from China are based on scientific and objective grounds,” Foreign Ministry spokesman Lim Soo-suk said in a briefing. “The government has been transparently sharing relevant information with the international community, and has continued to communicate with the Chinese side.”

The spat will likely rekindle memories of China’s decision to dramatically scale back trade with South Korea in 2017 after then-President Moon Jae-in agreed to host a US anti-missile system. Moon’s successor, President Yoon Suk Yeol, has in recent months raised Beijing’s ire by pledging to work more closely with the US, including expanding the missile shield.

South Korea said in late December that it would require Covid tests for all travelers from China by end of February, and would limit short-term visa issuance until the end of January. It also put the further increase in the number of flights from China on hold and directed existing flights to one airport.

China had warned earlier this month that it would hit back against such moves and Foreign Minister Qin Gang on Monday expressed concerns about South Korea’s travel curbs to his Korean counterpart Park Jin, according to the Chinese Foreign Ministry





Comments

Popular posts from this blog

Netanyahu’s Shocking Gaza Plan: ‘We Will Take Control of ALL of Gaza’ — But At What Cost?

  As Israeli forces intensify their offensive, Netanyahu vows total control of Gaza — but the humanitarian crisis is reaching a breaking point. Will the world stand by and watch? Israeli Prime Minister Benjamin Netanyahu has declared that Israel will “take control of all” of the Gaza Strip, signaling an unprecedented escalation in the ongoing conflict. In a video posted to Telegram, Netanyahu emphasized that military operations are advancing rapidly, with no intention of backing down. “The fighting is intense, and we are making progress,” he said, framing the offensive as necessary for Israel’s long-term security. But as international pressure mounts, his government is walking a tightrope between military dominance and global condemnation. The Israeli military has ordered mass evacuations in southern Gaza, warning residents of Khan Yunis and surrounding areas to flee immediately ahead of a devastating assault. Arabic-language spokesman Avichay Adraee described the coming attack as ...

Israel issues latest forced evacuation order in areas in Khan Younis

  The Israeli army’s Arabic-language spokesperson, Avichay Adraee, has issued the latest forced evacuation order for civilians living in nine areas in Khan Younis, southern Gaza. Adraee said that the army was expanding its operation and “intensifying sudden and concentrated firepower”. The spokesperson called on residents to evacuate westward. So-called Israeli safe zones, including Al-Mawasi in Khan Younis, are routinely attacked despite the army forcing Palestinians to move to those areas.

UAE initiates extensive CAR T-cell treatment in the region

The United Arab Emirates has transformed the medical structure of the region as it slowly moves towards attaining leadership in medical treatments and complex procedures. It has stepped up on the list with a pioneering treatment led by Abu Dhabi. The capital has witnessed a revolutionary process that focuses on the safety and efficacy of using the CAR T-Cell treatment module especially for hematologic or blood cancers such as lymphoma, myeloma, and certain types of leukemia. This is an exemplary step in the context of the region as it is the first of its kind treatment here.  On Saturday, the Emirati nation began its experiment to locally manufacture CAR T-Cell treatment at Abu Dhabi Stem Cells Center. The T-Cells will be locally reprogrammed and tested for their effectiveness so that they get better results when it comes to treating cancer.   The unit for the stem cell treatment ADSCC was founded in 2019 and since then it has grown threefold when it comes to experimenting wit...